Cue Biopharma, Inc. Business Operations Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Termination of License Agreement, dated September 9, 2022, between Cue Biopharma, Inc. and MIL 21E, LLC
Termination Agreements
Cue Biopharma, Inc.
Biotechnology
2022
First Amendment to the Exclusive Patent License and Research Collaboration Agreement with Merck Sharp & Dohme Corp. dated November 9, 2020
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Eighth Amendment to Collaboration, License and Option Agreement, dated December 7, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Seventh Amendment to Collaboration, License and Option Agreement, dated May 14, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Sixth Amendment to Collaboration, License and Option Agreement, dated February 14, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Fifth Amendment to Collaboration, License and Option Agreement, dated January 10, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Fourth Amendment to Collaboration, License and Option Agreement, dated December 18, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Third Amendment to Collaboration, License and Option Agreement, dated October 29, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Second Amendment to Collaboration, License and Option Agreement, dated August 5, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
First Amendment to Collaboration, License and Option Agreement, dated March 15, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated June 22, 2020
Sales Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2020
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated March 27, 2020
Sales Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2020
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated November 25, 2019
Sales Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2019
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated June 5, 2019
Sales Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2019
Collaboration, License and Option Agreement, by and between the Company and LG Chem, Ltd., dated as of November 6, 2018
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2018
Collaboration, License and Option Agreement, by and between the Company and LG Chem, Ltd., dated as of November 6, 2018
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2018
Exclusive Patent License and Research Collaboration Agreement between the Registrant and Merck Sharp & Dohme Corp. dated November 14, 2017
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2017
Exclusive Patent License and Research Collaboration Agreement between the Registrant and Merck Sharp & Dohme Corp. dated November 14, 2017
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2017
Exclusive Patent License and Research Collaboration Agreement between the Registrant and Merck Sharp & Dohme Corp. dated November 14, 2017
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2017
Form of Indemnification Agreement
Indemnification Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2017